Clinical Trial Update: MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial results comparing MK0954 to placebo for mild to moderate hypertension, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• MK0954

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2009-06-24